This study is a continuation of the pivotal trial studying the safety and efficacy of the Relay thoracic stent-graft system to treat thoracic aortic aneurysms. Efficacy is being evaluated by the device-related adverse event rate of endovascular repair (via the Relay thoracic stent-graft) through 1 year. Safety is being evaluated by comparing major adverse events through 1 year in subjects treated with the Relay thoracic stent-graft to those who underwent surgical repair.
Study Type
EXPANDED_ACCESS
Device implant
Arizona Heart Hospital
Phoenix, Arizona, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Florida
Gainesville, Florida, United States
Baptist Cardiac and Vascular Institute
Miami, Florida, United States
Indiana Heart Hospital
Indianapolis, Indiana, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
University of North Carolina
Chapel Hill, North Carolina, United States
East Carolina University
Greenville, North Carolina, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
...and 5 more locations